283 related articles for article (PubMed ID: 12588628)
1. Pharmacogenetics of the major polymorphic metabolizing enzymes.
Daly AK
Fundam Clin Pharmacol; 2003 Feb; 17(1):27-41. PubMed ID: 12588628
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of polymorphic drug metabolism.
Daly AK
J Mol Med (Berl); 1995 Nov; 73(11):539-53. PubMed ID: 8751138
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 in Pharmacogenetics: An Update.
Tornio A; Backman JT
Adv Pharmacol; 2018; 83():3-32. PubMed ID: 29801580
[TBL] [Abstract][Full Text] [Related]
4. [Genetic polymorphisms in xenobiotic metabolizing enzymes as a determinant of susceptibility to environmental mutagens and carcinogens in humans].
Ozawa S
Yakugaku Zasshi; 1997 Nov; 117(10-11):895-909. PubMed ID: 9414599
[TBL] [Abstract][Full Text] [Related]
5. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
6. Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
van Schaik RH
Invest New Drugs; 2005 Dec; 23(6):513-22. PubMed ID: 16267627
[TBL] [Abstract][Full Text] [Related]
7. Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation.
Zanger UM; Turpeinen M; Klein K; Schwab M
Anal Bioanal Chem; 2008 Nov; 392(6):1093-108. PubMed ID: 18695978
[TBL] [Abstract][Full Text] [Related]
8. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility.
Daly AK; Cholerton S; Armstrong M; Idle JR
Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):55-61. PubMed ID: 7698086
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphism and toxicology--with emphasis on cytochrome p450.
Johansson I; Ingelman-Sundberg M
Toxicol Sci; 2011 Mar; 120(1):1-13. PubMed ID: 21149643
[TBL] [Abstract][Full Text] [Related]
10. Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms.
Ingelman-Sundberg M
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):89-104. PubMed ID: 14574440
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk.
Bozina N; Bradamante V; Lovrić M
Arh Hig Rada Toksikol; 2009 Jun; 60(2):217-42. PubMed ID: 19581216
[TBL] [Abstract][Full Text] [Related]
12. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
13. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.
Kirchheiner J; Seeringer A
Biochim Biophys Acta; 2007 Mar; 1770(3):489-94. PubMed ID: 17113714
[TBL] [Abstract][Full Text] [Related]
15. The influence of genetic polymorphisms on population variability in six xenobiotic-metabolizing enzymes.
Ginsberg G; Smolenski S; Neafsey P; Hattis D; Walker K; Guyton KZ; Johns DO; Sonawane B
J Toxicol Environ Health B Crit Rev; 2009; 12(5-6):307-33. PubMed ID: 20183525
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics of drug-metabolizing enzymes in Italian populations.
Serpe L; Canaparo R; Scordo MG; Spina E
Drug Metab Pers Ther; 2015 Jun; 30(2):107-20. PubMed ID: 25527811
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 pharmacogenetics and cancer.
Rodriguez-Antona C; Ingelman-Sundberg M
Oncogene; 2006 Mar; 25(11):1679-91. PubMed ID: 16550168
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of the cytochromes P450.
Daly AK
Curr Top Med Chem; 2004; 4(16):1733-44. PubMed ID: 15579105
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
20. Polymorphic drug metabolism in anaesthesia.
Restrepo JG; Garcia-Martín E; Martínez C; Agúndez JA
Curr Drug Metab; 2009 Mar; 10(3):236-46. PubMed ID: 19442086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
